CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Optimistic About Upcoming Berubicin Trials After IND Approval
Berubicin is CNS Pharmaceuticals’ lead product candidate for treatment of Glioblastoma Multiforme, and has the potential to be the first…
Berubicin is CNS Pharmaceuticals’ lead product candidate for treatment of Glioblastoma Multiforme, and has the potential to be the first…
Ideanomics’ Mobility and Capital divisions provide shareholders with access to disruptive and high-growth opportunities The company’s primary shareholders include two…
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients…
Hunter Technology (TSX.V: HOC) (OTCQB: HOILF) (WKN: A2QEYH) (FSE: RWPM) has announced a planned April 2021 private release of its…
ISW Holdings (OTC: ISWH), a diversified portfolio comprised of essential business lines that serve consumer product demands in decentralized markets,…
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has announced the results of a new clinical study…
iClick Interactive Asia Group (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider, today announced the success of…
Uranium Energy (NYSE American: UEC), a Corpus Christi, Texas-based uranium mining and exploration company, today announced that Spencer Abraham, UEC's…
Mohawk Group (NASDAQ: MWK), a technology-enabled consumer products company, has scheduled a conference call to report fourth-quarter and year-end financial…
Sharing Services Global Corporation (OTCQB: SHRG), formerly Sharing Services Inc., today announced its plan to launch a new travel company,…